Features | Partner Sites | Information | LinkXpress
Sign In
TERARECON, INC.
AMPRONIX
SCHILLER AG

MR Software Designed for Improved Cardiac Exam Processing

By Medimaging International staff writers
Posted on 26 Feb 2013
New cardiac magnetic resonance imaging (MRI) software provides intuitive, rapid, semiautomatic analysis of basic cardiac parameters, allowing the user to create a comprehensive cardiac patient report within a streamlined clinical environment.

GE Healthcare’s (Chalfont St. Giles, UK) two new software packages for advanced analysis of cardiovascular magnetic resonance (MR) images are called the CardiacVX and MR VesselIQ Xpress. Both CardiacVX and MR VesselIQ Xpress were featured in the GE Healthcare booth at the annual meeting of the Society for Cardiac Magnetic Resonance (SCMR) on February 1-2, 2013, in San Francisco, CA, USA.

Cardiac MR can provide a large amount of data about the patient’s cardiac condition such as functional parameters, flow, and infarction. However, extricating this information and presenting it in an integrated fashion to the referring physician can be a time-consuming task for the technologist or clinician performing the study.

The US Food and Drug Administration (FDA) 510(k)-cleared CardiacVX runs on GE Healthcare’s Advantage workstation (AW), and provides a range of reproducible tools for rapid reviewing and reporting. CardiacVX performs, for instance, fast left ventricle segmentation and volumetric functional analysis in just two clicks. Additional tools include myocardial infarct evaluation, flow analysis (with Qp/Qs ratio), time-course analysis, iron-overload assessment, patent foramen ovale (PFO) assessment, and one-click customizable reporting macros, all within an intuitive, guided user interface.
“CardiacVX was designed to address the clinical demand for a more automated and user-friendly cardiac postprocessing tool to allow clinicians to quickly and easily arrive at needed diagnostic information,” said Anja Brau, PhD, manager of global cardiac MR applications for GE Healthcare.

Computed tomography (CT) angiography has been widely used for evaluating vascular stenosis or abnormalities, but even more, MR angiography is used because of the absence of radiation and calcium-blooming artifacts. Being able to use similar analysis workflow between CT and MR can greatly improve the clinician’s diagnostic efficiency. MR VesselIQ Xpress, built based on GE Healthcare’s CT VesselIQ Xpress platform, is an enhanced image analysis package for MR angiographic data to effectively analyze selected vessels for stenosis, directional tortuosity, and other vascular disorders. MR VesselIQ Xpress provides sophisticated applications such as automatic vessel tracking with centerline display of any vessel, fast three-dimensional (3D) visualization, and fast access to vessel cross section and profile images.

Moreover, MR VesselIQ Xpress automatically provides size, stenosis, and length measurements of abnormal anatomic structures with two deposited points. Measurement tables and associated images are taken and ready to be included in reports. This software was developed to aid radiologists and other clinicians in the effective assessment of vascular anatomy and disease.

CardiacVX and MR VesselIQ Xpress software packages run on GE’s AW and are compatible with AW releases 4.4, 4.5, and 4.6.

Related Links:
GE Healthcare


RADCAL
RTI ELECTRONICS AB
SuperSonic Imagine

Channels

MRI

view channel
Image: The quantitative character of the novel 3D technique on MR scans from a patient with primary liver cancer is demonstrated. Images A and B show the scan of the patient before being treated with chemoembolization. The new 3D technique helped quantify the volume and distribution of viable tumor tissue (shown in red and yellow colors). Images C and D demonstrate MR scans acquired after the treatment. The new 3D method helped the radiologists to quantify the vast central destruction of the tumor after the treatment (the dead tumor is represented by the blue color) (Photo courtesy of Johns Hopkins Medicine).

3D MRI Offers Improved Prediction of Survival After Chemotherapy for Liver Tumors

Researchers are using specialized three-dimensional (3D) magnetic resonance imaging (MRI) scanning technology to accurately measure living and dying liver tumor tissue in order to quickly show whether... Read more

Ultrasound

view channel
Image: Siemens Healthcare has launched the HELX Evolution, the newest iteration of its Acuson S range of ultrasound imaging systems (Photo courtesy of Siemens Healthcare).

Ultrasound Imaging System Enhancements Include High Definition Transducers, Sophisticated Elastography, and Tissue Strain Analysis

New features designed for a range of ultrasound systems include enhanced image quality with a large 21.5-inch liquid crystal diode (LCD) monitor, high definition (HD) transducers, optimized contrast agent... Read more

Nuclear medicine

view channel
Image: Sagittal section of brain PET image at four hours after 64CuCl2 injection with disulfiram or D-penicillamine in MD model mice (Photo courtesy of the RIKEN Center for Life Science Technologies).

PET Imaging Used to Assess Effectiveness of Menkes Disease Treatments

Japanese scientists are using positron emission tomography (PET) imaging to visualize the distribution of copper in the body using lab mice. Copper distribution is deregulated in a genetic disorder called... Read more

General/Advanced Imaging

view channel

Secondary Light Emission Generated by Plasmonic Nanostructures May Improve Medical Imaging Technology

New clues into light emission at different wavelengths generated by elements known plasmonic nanostructures may help to improve medical imaging technology. A plasmon is a quantum of plasma oscillation. The plasmon is a quasiparticle resulting from the quantization of plasma oscillations just as photons, and phonons are... Read more

Industry News

view channel

Collaboration Expands Capacity for Proton Therapy Clinical Research and Patient Treatments

Varian Medical Systems (Palo Alto, CA, USA) and the Paul Scherrer Institute (PSI; Villigen PSI, Switzerland) are extending an existing collaboration in the field of proton therapy to offer patients more accurate cancer treatments using intensity-modulated proton therapy (IMPT). Under the agreement, Varian will also... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.